15 Jun 2026 | Press release
We are pleased to share an important milestone for Technophage: the Phase 1/2a clinical study TP-122_101A has recently received the necessary regulatory approvals to move forward in Europe, specifically Portugal and the Netherlands. The study, entitled...
22 Dez 2025 | Press release
We are pleased to share that last Friday marked an important milestone for Technophage with the End of Study of the TP-102 Phase 2b clinical trial. We would like to sincerely thank our CRO partners, Principal Investigators, and hospital teams in the United States and...
